This page uses content from Wikipedia and is licensed under CC BY-SA.
|Trade names||Levarterenol, Levophed, Norepin, other|
|Source tissues||Locus coeruleus; sympathetic nervous system; adrenal medulla|
|Receptors||α1, α2, β1, β3|
|Agonists||Sympathomimetic drugs, clonidine, isoprenaline|
|Antagonists||Tricyclic antidepressants, Beta blockers, antipsychotics|
|Chemical and physical data|
|Molar mass||169.18 g/mol|
|3D model (JSmol)|
|Melting point||217 °C (423 °F) (decomposes)|
|Boiling point||442.6 °C (828.7 °F) ±40.0°C|
Norepinephrine, also known as noradrenaline, is a medication used to treat people with very low blood pressure. It is the typical medication used in sepsis if low blood pressure does not improve following intravenous fluids. It is the same molecule as the hormone and neurotransmitter norepinephrine. It is given by slow injection into a vein.
Common side effects include headache, slow heart rate, and anxiety. Other side effects include an irregular heartbeat. If it leaks out of the vein at the site it is being given, norepinephrine can result in limb ischemia. If leakage occurs the use of phentolamine in the area affected may improve outcomes. Norepinephrine works by binding and activating alpha adrenergic receptors.
Norepinephrine was discovered in 1946 and was approved for medical use in the United States in 1950. It is available as a generic medication. The wholesale cost in the developing world as of 2015 is about 0.42 USD per vial of four milligrams. In the United Kingdom this amount costs the NHS about 4.40 pounds.
Norepinephrine is used mainly as a sympathomimetic drug to treat people in vasodilatory shock states such as septic shock and neurogenic shock, while showing fewer adverse side-effects compared to dopamine treatment.
It stimulates α1 and α2 adrenergic receptors to cause blood vessel contraction, thus increases peripheral vascular resistance and resulted in increased blood pressure. This effect also reduces the blood supply to gastrointestinal tract and kidneys. Norepinephrine acts on beta-1 adrenergic receptors, causing increase in heart rate and cardiac output.
We recommend norepinephrine as the first-choice vasopressor (strong recommendation, moderate quality of evidence).